Market Overview

Therium Adds to Investment Team in New York with the Appointment of Elizabeth Korchin


Therium Group Holdings Ltd., a leading provider of litigation finance
globally, has added to its investment team with the appointment of
Elizabeth Korchin in New York.

This press release features multimedia. View the full release here:

Elizabeth Korchin (Photo: Business Wire)

Elizabeth Korchin (Photo: Business Wire)

Elizabeth, a graduate of Harvard Law School and Duke University, leaves
her post as a Partner at Hogan Lovells, from which she brings a
particular expertise in technology-related matters. Elizabeth's practice
at Hogan Lovells focused on high-stakes complex commercial litigation
and arbitration, as well as intellectual property disputes, on behalf of
Fortune 500 clients across major industries, including global consumer
electronics and telecommunications manufacturers, health insurers, and
technology companies. Her expertise spans a wide variety of areas of
substantive law, including Lanham Act, RICO, ERISA, False Claims Act,
antitrust, consumer protection, and contract claims, among others, and
she has handled all aspects of litigation including multiple jury
trials, bench trials, and international arbitration hearings on the
merits, as well as appellate proceedings.

Neil Purslow, Therium's Co-Founder and Chief Investment Officer,
observed: "We are continuing to see strong growth in global demand for
our litigation financing services, especially as we deploy our new £300m
fund. Elizabeth's deep and wide-ranging experience brings a valuable
perspective to our U.S. operations, and aligns brilliantly with
Therium's core sectors. Elizabeth is a fantastic addition to the group
and we are delighted that she has joined us."

"We specifically sought out Elizabeth for two equally important reasons:
her expertise as a highly accomplished litigator and trial attorney, and
her well-deserved reputation as an out-of-the-box thinker who lends a
shrewd yet practical perspective to complex legal issues," adds Eric
Blinderman, Head of Therium's U.S. operations
. "Patrick Dempsey, who
leads our U.S. investment team, experienced firsthand the unique value
and diverse perspective that Elizabeth brings to the table when they
worked together at Hogan Lovells. We look forward to benefiting from
Elizabeth's dynamism, fresh ideas and the unconventional approach that
earned her the reputation as an innovator and that will further
strengthen our team as we build on Therium's existing success in
bringing innovative products and services to the global litigation
funding industry."

Elizabeth will hit the ground running, as Therium is steadfastly
deploying a substantial portion of its latest fund in the United States
market, where demand for litigation funding continues to increase

"Therium has long been and remains a pioneer in litigation funding and I
am thrilled to be a part of Therium's continued transformation of the
legal financing landscape," Elizabeth said. "Coming from a global
platform at Hogan Lovells, I was especially attracted to Therium's
unparalleled global footprint in legal finance, not to mention their
deep experience and impressive track record. I couldn't be more excited
to continue to develop the industry with this incredible team."

About Therium

Founded in London and Jersey in 2009, Therium is a leading global
litigation financing firm with a market-leading track record of
generating superior returns for its investors. The firm works across all
forms of commercial litigation and arbitration and invests in a broad
range of complex commercial disputes, from securities and shareholder
actions, international arbitration, competition and antitrust cases,
through to intellectual property, insolvency and class actions.

In April 2016, Therium became the first European litigation finance
company to launch a full-service business in North America, which is
headquartered in New York. In June 2016, Therium introduced litigation
financing to Scandinavia when it opened an office in Oslo, and in March
2017, Therium launched in Germany as the country's first full service
litigation commercial funder.

In February 2018, Therium announced its latest fund, which will be £300m
upon the final close, and which the company is now actively deploying.
Upon final close of the new fund, Therium will have raised nearly £600
million since its foundation in 2009. To date, the firm globally has
funded claims valued at £36 billion.

Therium has consistently been at the forefront of innovation in
litigation finance, pioneering the combined use of insurance tools
alongside funding vehicles, and introducing portfolio funding products
into the UK. Therium's substantial footprint in the United States market
continues to steadily expand since it began its U.S. operations in 2016.
The firm's ability to develop innovative funding arrangements and
bespoke financial solutions for litigants and law firms complements its
unmatched experience and rigorous approach to funding a wide range of
commercial disputes in varying jurisdictions throughout the world.

View Comments and Join the Discussion!